Literature DB >> 7826642

p493F12 kinase: a novel MAP kinase expressed in a subset of neurons in the human nervous system.

A A Mohit1, J H Martin, C A Miller.   

Abstract

Monoclonal antibody 3F12 identifies a cytoplasmic antigen of 49 kDa in human hippocampus and neocortex. The distribution of 3F12 immunoreactive neurons closely matches that of Alzheimer's disease (AD) targeted neurons in these areas. In some hippocampal neurons of AD patients, this antigen colocalizes with ALZ-50, indicating the presence of AD pathology in these neurons. Molecular characterization of the 3F12 cDNA revealed it to be a member of the MAP kinase family, showing 43% amino acid sequence identity to human extracellular related kinase 2 (p42mapk). We have confirmed that p493F12 kinase autophosphorylates both threonine and tyrosine residues, as expected for a MAP kinase. The p49 mRNA is expressed exclusively in the nervous system. In the brain, the distribution of these neurons closely corresponds to 3F12 antigen-bearing neurons. The p493F12 gene maps to the human chromosome 21q21 region, a region that may be important in the pathogenesis of AD and Down's syndrome.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7826642     DOI: 10.1016/0896-6273(95)90241-4

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  57 in total

1.  Dual roles for c-Jun N-terminal kinase in developmental and stress responses in cerebellar granule neurons.

Authors:  E T Coffey; V Hongisto; M Dickens; R J Davis; M J Courtney
Journal:  J Neurosci       Date:  2000-10-15       Impact factor: 6.167

2.  Glutamate, but not dopamine, stimulates stress-activated protein kinase and AP-1-mediated transcription in striatal neurons.

Authors:  M A Schwarzschild; R L Cole; S E Hyman
Journal:  J Neurosci       Date:  1997-05-15       Impact factor: 6.167

3.  Stress- and cell type-dependent regulation of transfected c-Jun N-terminal kinase and mitogen-activated protein kinase kinase isoforms.

Authors:  L Butterfield; E Zentrich; A Beekman; L E Heasley
Journal:  Biochem J       Date:  1999-03-15       Impact factor: 3.857

4.  Opposite regulation of oligodendrocyte apoptosis by JNK3 and Pin1 after spinal cord injury.

Authors:  Qi Ming Li; Chhavy Tep; Tae Y Yune; Xiao Zhen Zhou; Takafumi Uchida; Kun Ping Lu; Sung Ok Yoon
Journal:  J Neurosci       Date:  2007-08-01       Impact factor: 6.167

Review 5.  Uses for JNK: the many and varied substrates of the c-Jun N-terminal kinases.

Authors:  Marie A Bogoyevitch; Bostjan Kobe
Journal:  Microbiol Mol Biol Rev       Date:  2006-12       Impact factor: 11.056

6.  Identification of novel M phase phosphoproteins by expression cloning.

Authors:  N Matsumoto-Taniura; F Pirollet; R Monroe; L Gerace; J M Westendorf
Journal:  Mol Biol Cell       Date:  1996-09       Impact factor: 4.138

Review 7.  Regulated phosphorylation and dephosphorylation of tau protein: effects on microtubule interaction, intracellular trafficking and neurodegeneration.

Authors:  M L Billingsley; R L Kincaid
Journal:  Biochem J       Date:  1997-05-01       Impact factor: 3.857

8.  JNK inhibition of VMAT2 contributes to rotenone-induced oxidative stress and dopamine neuron death.

Authors:  Won-Seok Choi; Hyung-Wook Kim; Zhengui Xia
Journal:  Toxicology       Date:  2014-12-09       Impact factor: 4.221

9.  TBP is differentially regulated by c-Jun N-terminal kinase 1 (JNK1) and JNK2 through Elk-1, controlling c-Jun expression and cell proliferation.

Authors:  Shuping Zhong; Jody Fromm; Deborah L Johnson
Journal:  Mol Cell Biol       Date:  2006-10-30       Impact factor: 4.272

10.  Inhibition of JNK mitochondrial localization and signaling is protective against ischemia/reperfusion injury in rats.

Authors:  Jeremy W Chambers; Alok Pachori; Shannon Howard; Sarah Iqbal; Philip V LoGrasso
Journal:  J Biol Chem       Date:  2012-12-20       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.